RadNet, Inc.

RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges

2026-08-09 16:00:00

Total Company Revenue increased 25.0% to a quarterly record of $622.7 million in the second quarter of 2026 from $498.2 million in the second quarter of 2025 Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 56.5% to a quarterly record of $32.4 million in the second quarter of 2026 from $20.7 million in the second quarter of 2025; Annual Recurring Revenue ( 4) (ARR) increased from $53.5 million at June 30, 2025 to $105.5 million at June 30, 2026 and sequentially increased from $96.9 million at March 31, 2026 Total Company Adjusted EBITDA ( 1) was a quarterly record of $99.7 million in the second quarter of 2026 as compared with $81.2 million in the second quarter of 2025, an increase of 22.7%; Digital Health reportable segment Adjusted EBITDA ( 1) was $2.5 million in the second quarter of 2026 compared with $3.4 million in the second quarter of 2025, the result of continued infrastructure investments to fuel growth Imaging Center Segment Adjusted EBITDA ( 1) margin increased by 17 basis points to 16.1% in the second quarter of 2026 from 16.0% in the second quarter of 2025 Adjusting for unusual or one-time items, Adjusted Earnings ( 3) was $23.2 million and Adjusted Earnings Per Share ( 3) was $0.29 for the second quarter of 2026 as compared with Adjusted Earnings ( 3) of $25.7 million and Adjusted Earnings Per Share ( 3) of $0.34 for the second quarter of 2025   As a percentage of total procedural volumes, advanced imaging increased by 238 basis points to 29.9% in the second quarter of 2026 from 27.5% in the second quarter of 2025 In the second quarter of 2026, aggregate advanced imaging (MRI, CT and PET/CT) procedural volumes increased 21.2% and same-center advanced imaging procedural volumes increased 9.6% as compared with the second quarter of 2025 As of June 30, 2026, balance sheet cash was $726.3 million and Net Debt to Adjusted EBITDA ( 1) Ratio ( 5 ) was 1.8x RadNet revises full-year 2026 Imaging Center guidance levels with increases to Revenue, Adjusted EBITDA ( 1) and Free Cash Flow ( 2 ) and reaffirms all Digital Health guidance ranges LOS ANGELES, Aug. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet” or the “Company”), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 442 owned and operated outpatient imaging centers, today reported financial results for its second quarter of 2026. Dr. Howard Berger, President and Chief Executive Officer of RadNet, commented, “The Imaging Center and Digital Health reportable operating segments continue to demonstrate strong growth and achieve record quarterly results.

Countdown to RadNet (RDNT) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

2026-08-06 10:16:09

Besides Wall Street's top-and-bottom-line estimates for RadNet (RDNT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.

DeepHealth Receives FDA Clearance for AI-Powered Breast Ultrasound

2026-07-30 16:15:00

SOMERVILLE, Mass., July 30, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced FDA 510(k) clearance for DeepHealth Breast Ultrasound,1 an AI-powered solution that brings greater standardization, clinical accuracy and efficiency to breast ultrasound imaging.

5 Takeover Targets for the AI Revolution

2026-07-26 12:00:00

Tom Yeung here with your Sunday Digest . In the 2010s, getting acquired was the ultimate startup status symbol.

RadNet, Inc. Announces Date of its Second Quarter 2026 Financial Results Conference Call

2026-07-22 06:00:00

LOS ANGELES, July 22, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers and digital health solutions, announced today that it will host a conference call to discuss its second quarter 2026 financial results on Monday, August 10, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

Bessemer Group Inc. Has $30.75 Million Stock Position in RadNet, Inc. $RDNT

2026-07-19 04:27:34

Bessemer Group Inc. grew its holdings in shares of RadNet, Inc. (NASDAQ: RDNT) by 11.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 550,172 shares of the medical research company's stock after purchasing an additional 56,173 shares during the quarter. Bessemer

RDNT's Unit DeepHealth Expands AI Breast Suite With FDA-Cleared Tools

2026-06-29 10:55:56

RadNet's DeepHealth gains FDA clearances for AI breast imaging tools that assess cardiovascular risk and compare prior mammograms.

DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite

2026-06-25 06:00:00

SOMERVILLE, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), announces it has received FDA 510(k) clearances for two new Breast Suite1 functionalities: Breast Arterial Calcification (BAC) Assessment, a tool applied to standard screening mammograms that automatically identifies breast arterial calcifications, a potential early indicator of cardiovascular disease;2 Prior exam integration into ProFound Pro, which enables automatic processing of prior and current studies to track prior lesions and distinguish new lesions, with the goal of improving cancer detection rates and reducing recalls.